APOE and Alzheimer disease: The formulation of caprylic triglyceride, also known as AC-12-010, was administered daily (40 g powder mixed with 4–8 oz of water) for 26 weeks in APOE4 non-carrier subjects with a diagnosis of mild-to-moderate AD.